Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Medicina y Seguridad del Trabajo
versión On-line ISSN 1989-7790versión impresa ISSN 0465-546X
Resumen
LLUCH HERNANDEZ, Ana. New Challenges in the treatment and research of breast cancer. Med. segur. trab. [online]. 2016, vol.62, suppl., pp.113-115. ISSN 1989-7790.
Cancer therapy has undergone major developments that have occurred with unusual speed. The therapeutic arsenal has intensified in effectively having cytostatic or what is commonly known as "chemo" drugs of different mechanisms of action that induce apoptosis or cell death but its poor specificity to attack only the tumor cell, affecting also healthy cells. New therapies directed against a specific target, a protein or a membrane receptor located on the tumor cell recently shown, The first antidiana therapies were introduced intravenously administered monoclonal antibodies, however in recent years have witnessed a real "boom" with the development of a new family of oral targeted therapies, called tyrosine kinase inhibitors. These developments in support of surgery and oncoradiología with its spectacular advances in recent years have contributed very significantly to improved disease control or quality of life of patients.
Palabras clave : New treatment; Breast cancer.